27.09.2014 Views

The Toxicologist - Society of Toxicology

The Toxicologist - Society of Toxicology

The Toxicologist - Society of Toxicology

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

167 STUDIES OF LONG-TERM PROTEIN CHANGES IN<br />

RATS NEONATALLY TREATED WITH THE<br />

CYANOBACTERIAL TOXIN β-N-METHYLAMINO-L-<br />

ALANINE (BMAA) USING MALDI IMAGING MASS<br />

SPECTROMETRY.<br />

O. Karlsson, E. Roman, E. Brittebo and M. Andersson. Pharmaceutical<br />

Biosciences, Uppsala University, Uppsala, Sweden. Sponsor: M. Stigson.<br />

Most cyanobacteria (blue-green algae) found in aquatic and terrestrial environments<br />

can produce the toxin BMAA. Dietary exposure to BMAA has been suggested<br />

to be involved in the etiology <strong>of</strong> amyotrophic lateral sclerosis/Parkinsonismdementia<br />

complex. Our previous studies have revealed an uptake <strong>of</strong> BMAA in the<br />

hippocampus and striatum <strong>of</strong> neonatal mice. Furthermore, neonatal rats treated<br />

with BMAA displayed acute but transient motoric disturbances and failed to show<br />

habituation at juvenile age. In addition, neonatal BMAA administration induced<br />

long-term learning impairments in adult rats.<br />

<strong>The</strong> aim <strong>of</strong> the present study was to search for molecular correlates <strong>of</strong> changed<br />

learning behavior in the brain <strong>of</strong> the adult rats used in the behavior studies. Wistar<br />

rats were given BMAA on postnatal day 9–10 (200 or 600 mg/kg; sc injection) and<br />

Matrix Assisted Laser Desorption Ionization (MALDI) Imaging Mass<br />

Spectrometry (IMS) was used to assess regional distribution and protein levels at<br />

adult age. Primarily MALDI IMS is focused on brain structures that are important<br />

for spatial learning and memory formation, including hippocampus and striatum<br />

that were previously demonstrated to have a selective uptake after neonatal exposure.<br />

Brain sections were thaw-mounted onto MALDI compatible glass slides and<br />

picoliter-sized droplets <strong>of</strong> sinapinic acid and 2,4,-dihydroxyacetophenone matrix<br />

were deposited in arrays across the sections using a robotic microdispenser. Mass<br />

spectra were acquired from each matrix deposition on a Bruker Ultraflex II<br />

MALDI-TOF operated in linear mode. <strong>The</strong>re were more than 300 small proteins<br />

in the mass range between 2000-20 000 Da in every mass spectrum. <strong>The</strong> preliminary<br />

data evaluation revealed that the BMAA-treated groups expressed a lower level<br />

<strong>of</strong> 18 kDa Myelin basic protein (MBP) but not <strong>of</strong> the 14 kDa MBP is<strong>of</strong>orm in the<br />

striatum. Other proteins <strong>of</strong> unknown identity also demonstrated treatment-related<br />

changes and could be involved in the BMAA-induced learning impairments.<br />

168 EFFECT OF DEVELOPMENTAL CHLORPYRIFOS<br />

EXPOSURE ON ENDOCANNABINOID<br />

METABOLIZING ENZYMES IN THE BRAIN OF<br />

JUVENILE RATS.<br />

R. L. Carr and M. K. Ross. Center for Environmental Health Sciences, Mississippi<br />

State University, Mississippi State, MS.<br />

<strong>The</strong> endogenous cannabinoids 2-arachidonylglycerol (2-AG) and anandamide<br />

(AEA) play vital roles during nervous system development including regulating axonal<br />

guidance and synaptogenesis. <strong>The</strong> degradation <strong>of</strong> 2-AG and AEA is mediated<br />

by monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), respectively.<br />

Both enzymes are highly susceptible to inhibition by organophosphate<br />

compounds in vitro, and acute in vivo exposure <strong>of</strong> adult animals to the agricultural<br />

insecticide chlorpyrifos (CPS) results in moderate inhibition <strong>of</strong> both MAGL and<br />

FAAH at 30 mg/kg and elevated the levels <strong>of</strong> the endocannabinoids at 100 mg/kg.<br />

However, the effects <strong>of</strong> repeated exposure to lower levels <strong>of</strong> CPS, especially during<br />

development, on endocannabinoid metabolism in the brain is not known. To determine<br />

this, rat pups were exposed daily from days 10-16 to CPS (5 mg/kg) either<br />

orally dissolved in corn oil (PO-Oil) or subcutaneously dissolved in DMSO (SC-<br />

DMSO). A representative vehicle/route control group was present for each treatment.<br />

At 6 hrs post-exposure, the activities <strong>of</strong> acetylcholinesterase (AChE), MAGL,<br />

and FAAH were determined in the forebrain. AChE inhibition in the SC-DMSO<br />

and PO-Oil groups was 75% and 50%, respectively. No significant effect on<br />

MAGL activity was observed in either treatment group. However, FAAH activity<br />

was virtually eliminated with inhibition ranging from 93% in the PO-Oil group to<br />

100% in the SC-DMSO group. This extensive inhibition <strong>of</strong> FAAH suggests the potential<br />

for accumulation <strong>of</strong> AEA resulting in activation <strong>of</strong> endocannabinoid transmission<br />

during brain maturation. This could have implications for the appropriate<br />

development <strong>of</strong> the endocannabinoid system leading to permanent alterations in<br />

neuronal brain circuits and behavioral responses.<br />

169 PHENCYCLIDINE (PCP) INDUCED CELL DEATH AND<br />

CHANGES IN GENE EXPRESSION.<br />

F. Liu 1 , N. Sadovova 3 , X. Zou 1 , X. Zhang 1 , L. Shi 2 , L. Guo 2 , F. Qian 4 , Z.<br />

Wen 4 , T. Patterson 1 , J. Hanig 5 , M. Paule 1 , W. Slikker 1 and C. Wang 1 .<br />

1<br />

Division <strong>of</strong> Neurotoxicology, National Center for Toxicological Research, Jefferson,<br />

AR, 2<br />

Division <strong>of</strong> Systems <strong>Toxicology</strong>, National Center for Toxicological Research/U.S.<br />

Food & Drug Administration, Jefferson, AR, 3<br />

Toxicologic Pathology Associates,<br />

Jefferson, AR, 4<br />

Z-Tech, an ICF International Company at NCTR, Jefferson, AR and<br />

5<br />

5Center for Drug Evaluation and Research/U.S. Food & Drug Administration,<br />

Silver Spring, MD.<br />

Repetitive administration (perinatal) <strong>of</strong> PCP, an N-methyl-D-aspartate (NMDA)<br />

receptor antagonist, may result in cortical apoptosis and long-lasting behavioral<br />

deficits. <strong>The</strong> present study examined the potential neurotoxic effects <strong>of</strong> PCP on<br />

postnatal day (PND) 7 rat pups and the possible underlying mechanism. PND 7<br />

rats were subcutaneously administered 10 mg/kg PCP or saline (control) on PNDs<br />

7, 9, and 11, and 24 hours later the rats were sacrificed and brain tissues were harvested<br />

for RNA extraction and morphological assessments. RNA samples were collected<br />

from frontal cortical levels and hybridized to Illumina Rat Ref-12 Expression<br />

BeadChips containing 22,226 probes. <strong>The</strong> criteria used for selecting the differentially<br />

expressed genes (DEGs) were a fold-change greater than 1.4 (up or down) and<br />

a P-value less than 0.05 when comparing the PCP treatment group to the control<br />

group. Based on these criteria, 19 genes were up-regulated and 24 genes were down<br />

regulated. Among them, 6 up-regulated genes are pro-apoptotic, and 8 down-regulated<br />

genes are anti-apoptotic factors, which may have the potential to induce apoptosis.<br />

Using histochemical approaches, elevated neuronal cell death was evident in<br />

PCP-treated brains. Consistent with previous observations, DNA microarray data<br />

indicated a significant up-regulation <strong>of</strong> NMDA receptor NR1 subunit mRNA in<br />

the PCP group. <strong>The</strong>se findings support the working hypothesis that the apoptosis<br />

produced by PCP is, at least in part, through the up-regulation <strong>of</strong> NMDA receptors,<br />

which makes neurons possessing these receptors more vulnerable, after PCP<br />

washout, to the excitotoxic effects <strong>of</strong> endogenous glutamate. Supported by<br />

NCTR/NTP IAG # 244-07-0007 (E-2155).<br />

170 RECOMMENDATIONS FOR DEVELOPING<br />

ALTERNATIVE TEST METHODS FOR<br />

DEVELOPMENTAL NEUROTOXICITY.<br />

K. Cr<strong>of</strong>ton 1 , L. Buzanska 2 , S. Coecke 2 , H. Knaut 3 , P. Lein 4 , W. Mundy 1 , A.<br />

Price 2 , A. Seiler 5 and A. Goldberg 6 . 1 Integrated Systems <strong>Toxicology</strong>, U.S. EPA,<br />

Research Triangle Park, NC, 2 Joint Research Council, Ispra, Italy, 3 Skirball Institute,<br />

New York University School <strong>of</strong> Medicine, NYC, NY, 4 Molecular Biosciences, U.S.<br />

Davis, Davis, CA, 5 ZEBET, Berlin, Germany and 6 CAAT, Johns Hopkins University,<br />

Baltimore, MD.<br />

<strong>The</strong>re is great interest in developing alternative methods for developmental neurotoxicity<br />

testing (DNT) that are cost-efficient, use fewer animals and are based on<br />

current scientific knowledge <strong>of</strong> the developing nervous system. Alternative methods<br />

will require demonstration <strong>of</strong> their predictive ability as well as the development and<br />

acceptance <strong>of</strong> a strategy for data interpretation. <strong>The</strong>refore, an international group <strong>of</strong><br />

experts developed a set <strong>of</strong> recommendations to facilitate development <strong>of</strong> alternative<br />

DNT test methods. <strong>The</strong> intent <strong>of</strong> the document is to engage the research community<br />

in the development <strong>of</strong> in vitro and alternative DNT methods, to stimulate discussion<br />

and to facilitate comparative evaluations <strong>of</strong> candidate models. Definitions<br />

for endpoint, test system and test method were adopted from previously published<br />

OECD guidance documents. Fourteen criteria deemed important for DNT test<br />

method development are proposed to address issues <strong>of</strong> relevance to human neurodevelopment,<br />

specificity, sensitivity and comparison <strong>of</strong> data within and between<br />

laboratories. <strong>The</strong>se criteria are applicable to new approaches and are meant to stimulate<br />

input <strong>of</strong> new scientific knowledge into the development <strong>of</strong> alternative DNT<br />

methods. This abstract does not necessarily reflect the policy <strong>of</strong> the U.S. EPA.<br />

171 ASSESSING LATER-LIFE BEHAVIORAL PHENOTYPES<br />

IN RESPONSE TO PRENATAL EXPOSURE TO<br />

BENZOPYRENE.<br />

M. McCallister 1 , M. Maguire 1 , A. Ramesh 3 and D. B. Hood 1, 2 . 1 Center for<br />

Molecular and Behavioral Neuroscience, Meharry Medical College, Nashville, TN,<br />

2<br />

Department <strong>of</strong> Pharmacology and <strong>The</strong> Brain Institute, Vanderbilt University School<br />

<strong>of</strong> Medicine, Nashville, TN and 3 Department <strong>of</strong> Biochemistry and Cancer Biology,<br />

Meharry Medical College, Nashville, TN.<br />

Benzo(a)pyrene is an environmental contaminant that is a member <strong>of</strong> the polycyclic<br />

aromatic hydrocarbon (PAH) family. It was reported that environmental levels<br />

encountered in the air <strong>of</strong> New York City can affect child IQ scores adversely.<br />

36 SOT 2010 ANNUAL MEETING

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!